Bipolar disorder (BD) is a prevalent and disabling condition, often comorbid with other medical and psychiatric conditions and frequently misdiagnosed. International treatment guidelines for BD recommend the use of mood stabilizers either in monotherapy or in association as the gold standard in both acute and long-term therapy. Commonly used in the clinical practice of BD, mood stabilizers have represented an evolving field over the last few years. The concept of stabilization, in fact, has been stressed as the ultimate objective of the treatment of BD, given the chronic and recurrent nature of the illness, which accounts for its significant levels of impairment and disability. To date, different compounds are included within the broad class of mood stabilizers, with lithium, anticonvulsants and, more recently, atypical antipsychotics being the most representative agents. This article is aimed at providing an updated review of the available literature in relation to the role of mood stabilizers in BD, with particular emphasis on their mechanism of action, main clinical aspects and specific use in the different phases of BD treatment, according to the most recently published international treatment guidelines.
Mood stabilizers for patients with bipolar disorder : the state of the art / A.C. Altamura, L. Lietti, C.R.M. Dobrea, B. Benatti, C. Arici, B.M. Dell'Osso. - In: EXPERT REVIEW OF NEUROTHERAPEUTICS. - ISSN 1473-7175. - 11:1(2011 Jan), pp. 85-99.
|Titolo:||Mood stabilizers for patients with bipolar disorder : the state of the art|
ALTAMURA, ALFREDO CARLO (Primo)
LIETTI, LICIA (Secondo)
DELL'OSSO, BERNARDO MARIA (Ultimo)
|Parole Chiave:||acute treatment; anticonvulsants; atypical antipsychotics; bipolar disorder; depression; lithium; maintenance treatment; mania; mood stabilizers|
|Settore Scientifico Disciplinare:||Settore MED/25 - Psichiatria|
|Data di pubblicazione:||gen-2011|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1586/ERN.10.181|
|Appare nelle tipologie:||01 - Articolo su periodico|